mortality/aging
• survival at 20 months is reduced compared to Nos3 or Nos1 single mutant mice
|
• survival at 20 months is reduced compared to Nos3 or Nos1 single mutant mice
• the relative risk of death by 20 months of age is increased 7.3 fold compared to Nos3 single mutants and 3.0 fold compared to Nos1 single mutants
• mortality is increased in males compared to females
|
cardiovascular system
• develop age related concentric remodeling with marked increase in relative wall thickness
• increase in wall thickness and decrease in systolic and diastolic dimensions with age
|
• attenuation of the beta-adrenergic inotropic responses indicating a decrease in myocardial contractile reserve
|
• increase in basal contractility
• hypertrophy is associated with hypercontractility
|
• hypertrophy is associated with increased diastolic stiffness
|
• relative to wild-type mice and Nos3 single mutants
|
• identical to that in Nos3 single mutants
|
muscle
• develop age related concentric remodeling with marked increase in relative wall thickness
• increase in wall thickness and decrease in systolic and diastolic dimensions with age
|
• attenuation of the beta-adrenergic inotropic responses indicating a decrease in myocardial contractile reserve
|
• increase in basal contractility
• hypertrophy is associated with hypercontractility
|
• hypertrophy is associated with increased diastolic stiffness
|
growth/size/body
• develop age related concentric remodeling with marked increase in relative wall thickness
• increase in wall thickness and decrease in systolic and diastolic dimensions with age
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
hypertrophic cardiomyopathy | DOID:11984 | J:129064 |